English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1157]
News [2523]
Articles [155]
Editorials [8]
Conferences [103]
elearning [18]
ASCO 2025: Importance of early testing in metastatic prostate cancer
Prof Eleni Efstathiou, Dr Elena Castro, Prof Gerhardt Attard and Dr Brigida...
ASCO 2025: Importance of early testing in metastatic prostate cancer ( Prof Eleni Efstathiou, Dr Elena Castro, Prof Gerhardt Attard and Dr Brigida Maiorano )
3 Jun 2025
HPK1 inhibitor NDI-101150 shows safety and antitumour activity in ccRCC
Dr David Braun - Yale School of Medicine, New Haven, USA
HPK1 inhibitor NDI-101150 shows safety and antitumour activity in ccRCC ( Dr David Braun - Yale School of Medicine, New Haven, USA )
2 Jun 2025
Tumour microenvironment and circulating biomarkers predict response to...
Dr David Braun - Yale School of Medicine, New Haven, USA
Tumour microenvironment and circulating biomarkers predict response to immunotherapy in advanced RCC ( Dr David Braun - Yale School of Medicine, New Haven, USA )
2 Jun 2025
Sacituzumab govitecan shows efficacy signals in muscle-invasive urothelial...
Dr Brigida Maiorano - IRCCS San Raffaele Hospital, Milan, Italy
Sacituzumab govitecan shows efficacy signals in muscle-invasive urothelial bladder cancer ( Dr Brigida Maiorano - IRCCS San Raffaele Hospital, Milan, Italy )
2 Jun 2025
ASCO 2025: Latest updates in mRCC
Dr Michael Serzan, Dr Guillermo De Velasco, Dr Alessandro Rametta and Dr Javier...
ASCO 2025: Latest updates in mRCC ( Dr Michael Serzan, Dr Guillermo De Velasco, Dr Alessandro Rametta and Dr Javier Puente )
2 Jun 2025
Nivolumab plus ipilimumab vs gemcitabine-carboplatin in cisplatin-ineligible...
Dr Michiel Simon van der Heijden - Netherlands Cancer Institute, Amsterdam...
Nivolumab plus ipilimumab vs gemcitabine-carboplatin in cisplatin-ineligible metastatic urothelial carcinoma ( Dr Michiel Simon van der Heijden - Netherlands Cancer Institute, Amsterdam, Netherlands )
2 Jun 2025
New MOAs in prostate cancer treatment - what’s next?
Dr Joaquin Mateo, Dr Andrew Parsonson and Dr Capucine Baldini
New MOAs in prostate cancer treatment - what’s next? ( Dr Joaquin Mateo, Dr Andrew Parsonson and Dr Capucine Baldini )
2 Jun 2025
QoL maintained with sasanlimab plus BCG in high-risk, BCG-naive NMIBC
Prof Jens Bedke - Klinikum Stuttgart-Katharinenhospital, Stuttgart, Germany
QoL maintained with sasanlimab plus BCG in high-risk, BCG-naive NMIBC ( Prof Jens Bedke - Klinikum Stuttgart-Katharinenhospital, Stuttgart, Germany )
2 Jun 2025
QoL improvements ID'd in phase 3 ARANOTE trial for mHSPC
Dr Alicia Morgans - Dana-Farber Cancer Institute, Boston, USA
QoL improvements ID'd in phase 3 ARANOTE trial for mHSPC ( Dr Alicia Morgans - Dana-Farber Cancer Institute, Boston, USA )
2 Jun 2025
BCG combined with mitomycin offers improved adjuvant treatment regimen for high...
Prof Dickon Hayne - University of Western Australia, Perth, Australia
BCG combined with mitomycin offers improved adjuvant treatment regimen for high-risk NMIBC ( Prof Dickon Hayne - University of Western Australia, Perth, Australia )
1 Jun 2025
CtDNA useful biomarker for muscle-invasive bladder cancer patients who received...
Prof Thomas Powles - Barts Cancer Institute, London, England
CtDNA useful biomarker for muscle-invasive bladder cancer patients who received perioperative durvalumab ( Prof Thomas Powles - Barts Cancer Institute, London, England )
31 May 2025
Sasanlimab BCG combo improves outcomes in high-risk NMIBC
Prof Thomas Powles - Barts Cancer Institute, London, England
Sasanlimab BCG combo improves outcomes in high-risk NMIBC ( Prof Thomas Powles - Barts Cancer Institute, London, England )
31 May 2025
<12345...97>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top